SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-22-000008
Filing Date
2022-04-21
Accepted
2022-04-21 16:04:59
Documents
14
Period of Report
2022-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kron-20220420.htm   iXBRL 8-K 40195
2 EX-10.1 kronosbio-2022severanceand.htm EX-10.1 133721
  Complete submission text file 0001741830-22-000008.txt   329925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20220420.xsd EX-101.SCH 2178
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20220420_def.xml EX-101.DEF 2941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20220420_lab.xml EX-101.LAB 28000
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20220420_pre.xml EX-101.PRE 15357
8 EXTRACTED XBRL INSTANCE DOCUMENT kron-20220420_htm.xml XML 11694
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 22841430
SIC: 2834 Pharmaceutical Preparations